news
Mironid secures £4.3 million in Series A funding
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
List view / Grid view
Oncology
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
news
Researchers identify the molecular mechanism of thalidomide
20 June 2016 | By Victoria White, Digital Content Producer
The new findings on thalidomide, from researchers at the Technical University of Munich (TUM), are highly relevant to current cancer therapies...
news
Cell Medica and Baylor to co-develop next generation cellular immunotherapies
17 June 2016 | By Victoria White, Digital Content Producer
Cell Medica has entered into a co-development partnership with Baylor to develop technologies for engineering immune cells with enhanced functions...
news
Investigating cancer resistance in naked mole-rats
16 June 2016 | By Victoria White, Digital Content Producer
Researchers believe understanding the anti-cancer mechanisms of naked mole-rats may help advance human treatment in the future...
news
Blocking LRH-1 causes liver cancer cells to starve
13 June 2016 | By Victoria White, Digital Content Producer
Scientists at EPFL have found a way to starve liver cancer cells by blocking a protein that is required for glutamine breakdown - LRH-1...
news
Reprogramming corrupted immune cells to attack tumours
13 June 2016 | By Victoria White, Digital Content Producer
Researchers at EPFL have found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumour...
news
Novel radioimmunotherapy results in complete remission in preclinical colorectal cancer study
13 June 2016 | By Victoria White, Digital Content Producer
Researchers have unveiled a novel radioimmunotherapy that resulted in complete remission of colorectal cancer in mouse models...
news
JQ1 found to alter how breast cancer cells respond to hypoxia
13 June 2016 | By Victoria White, Digital Content Producer
Results from a study showed that JQ1 slowed tumour growth and limited the number of blood vessels that were produced...
news
Biomarkers that could give better cancer survival estimates
9 June 2016 | By Victoria White, Digital Content Producer
A new method, developed by UCLA scientists, could eventually lead to a way to improve accuracy of how well a patient will respond to treatment...
article
Mechanism-informed phenotypic screening – the missing link for cancer drug discovery?
Cancer cells exhibit huge phenotypic diversity, with many well-defined phenotypes, such as invasion, deregulated proliferation and immune evasion, contributing to disease outcomes, making them uniquely amenable to phenotypic screening1...
news
Genomic Data Commons to accelerate cancer treatment research
6 June 2016 | By Victoria White, Digital Content Producer
The Genomic Data Commons (GDC), a unified data system that promotes sharing of genomic and clinical data between researchers, launched today...
news
Nek1 has ‘tremendous potential’ for treating cancer
3 June 2016 | By Victoria White, Digital Content Producer
Researchers have identified an enzyme, Nek1, that separates DNA replication from repair. The discovery could be significant in the treatment of tumours...
news
Bellicum and LUMC team up to discover TCR product candidates
2 June 2016 | By Victoria White, Digital Content Producer
The new collaboration builds on an earlier agreement with LUMC that gave Bellicum worldwide rights to TCR product candidates targeting solid tumours...
news
New study to develop a vaccine for glioblastoma multiforme
2 June 2016 | By Victoria White, Digital Content Producer
Researchers have initiated a new preclinical study aimed at developing a vaccine for the treatment of glioblastoma multiforme using ImmunoBody technology...
news
Incyte and Moffitt team up for blood cancer research programmes
1 June 2016 | By Victoria White, Digital Content Producer
Incyte has agreed to provide funding to conduct three new Moffitt Cancer Centre research programmes over a period of three years...
